Control of Pregnancy Associated Malaria With Intermittent Preventive Treatment
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Malaria
Related studies linked through entity extraction aliases.
Efficacy, Safety and Pharmacokinetic of ArtequinTM P. Falciparum Malaria
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Amodiaquine and Amodiaquine-Artesunate
- Status
- UNKNOWN
- Phase
- PHASE4
Age of Exposure and Immunity to Malaria in Infants
- Status
- COMPLETED
- Phase
- NA
Efficacy of Chloroquine + Sulfadoxine Pyrimethamine Versus Artemether + Lumefantrine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in the Philippines
- Status
- COMPLETED
- Phase
- NA
Effects of Insecticide Treated Bednets on Child Morbidity and Mortality
- Status
- COMPLETED
- Phase
- NA
Treatment of Malaria in Gabon With Fosmidomycin-Clindamycin
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Praziquantel Treatment on Schistosoma Mansoni Morbidity and re-Infection Along Lake Victoria, Uganda
- Status
- COMPLETED
- Phase
- NA
Efficacy of Fosmidomycin-Clindamycin for Treating Malaria in Gabonese Children
- Status
- COMPLETED
- Phase
- PHASE3
IPTi in Mozambican Infants for Malaria Prevention
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intermittent Treatment With Sulfadoxine-pyrimethamine for Malaria Control in Infants
- Status
- COMPLETED
- Phase
- PHASE4
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
- Status
- COMPLETED
- Phase
- NA
Combination Antimalarials in Uncomplicated Malaria
- Status
- COMPLETED
- Phase
- NA
A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
- Status
- COMPLETED
- Phase
- NA
A Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Candidate Vaccines RTS,S/AS02D (0.5 mL Dose) and RTS,S/AS02A (0.25 mL Dose) Administered IM According to a 0, 1, 2 Month Vaccination Schedule in Children Aged 3 to 5 Years Living in a Malaria-endemic Region of Mozambique.
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety, Immunogenicity and Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Malaria Vaccine RTS,S/AS02A, When Administered to Children Aged 1 to 4 Years Living in a Malaria-endemic Region of Mozambique.
- Status
- COMPLETED
- Phase
- PHASE2
Examine Safety and Immune Responses of GSK 257049 Vaccine When Administered to Infants Living in a Malaria-endemic Region
- Status
- COMPLETED
- Phase
- PHASE2
Contrast-Enhanced US of Spleen, Liver and Kidney
- Status
- UNKNOWN
- Phase
- N/A
A Stitch in Time May Save Lives: Turning Poor Bednets Into Good Ones
- Status
- COMPLETED
- Phase
- NA
Impact of Insecticide-treated Curtains on Antimalarial Drug Resistance
- Status
- COMPLETED
- Phase
- NA